Tech Company Financing Transactions

Jazz Pharmaceuticals Funding Round

Jazz Pharmaceuticals closed a $250 million Series B funding round on 3/24/2004. Investors included Adams Harkness Ventures, EGS Healthcare Capital Partners and Golden Gate Capital.

Transaction Overview

Announced On
3/24/2004
Transaction Type
Venture Equity
Amount
$250,000,000
Round
Series B
Proceeds Purpose
This financing enables us to simultaneously build our commercial organization and expand our portfolio of early and late-stage development projects, thereby creating robust neurology and psychiatry franchises

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
Waterloo Rd. Waterloo Exchange
Dublin 4, CA D04
Ireland
Email Address
Overview
Jazz (Nasdaq: JAZZ) is a pharmaceutical company focusing on improving the lives of patients through the development and commercialization of neurological and psychiatric products. We are committed to working closely with patients, patient advocacy groups and healthcare professionals.
Profile
Jazz Pharmaceuticals LinkedIn Company Profile
Social Media
Jazz Pharmaceuticals Company Twitter Account
Company News
Jazz Pharmaceuticals News
Facebook
Jazz Pharmaceuticals on Facebook
YouTube
Jazz Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Bruce Cozadd
  Bruce Cozadd LinkedIn Profile  Bruce Cozadd Twitter Account  Bruce Cozadd News  Bruce Cozadd on Facebook
Chief Financial Officer
Renée Galá
  Renée Galá LinkedIn Profile  Renée Galá Twitter Account  Renée Galá News  Renée Galá on Facebook
Chief Operating Officer
Daniel Swisher
  Daniel Swisher LinkedIn Profile  Daniel Swisher Twitter Account  Daniel Swisher News  Daniel Swisher on Facebook
Executive Vice President
Michael Miller
  Michael Miller LinkedIn Profile  Michael Miller Twitter Account  Michael Miller News  Michael Miller on Facebook
VP - Engineering
Finbar Larkin
  Finbar Larkin LinkedIn Profile  Finbar Larkin Twitter Account  Finbar Larkin News  Finbar Larkin on Facebook
VP - Human Resources
Heidi Manna
  Heidi Manna LinkedIn Profile  Heidi Manna Twitter Account  Heidi Manna News  Heidi Manna on Facebook
VP - R & D
Robert Iannone
  Robert Iannone LinkedIn Profile  Robert Iannone Twitter Account  Robert Iannone News  Robert Iannone on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/24/2004: VideoCodes venture capital transaction
Next: 3/24/2004: CloudShield Technologies venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary